Endoscopy 2000; 32(7): 512-519
DOI: 10.1055/s-2000-3817
Original Article
Georg Thieme Verlag Stuttgart · New York

Bucrylate Treatment of Bleeding Gastric Varices: 12 Years' Experience

R. Kind, A. Guglielmi, L. Rodella, F. Lombardo, F. Catalano, A. Ruzzenente, G. Borzellino, R. Girlanda, F. Leopardi, F. Pratticò, C. Cordiano
  • Emergency Endoscopic Service, First Surgical Department, Università di Verona, Verona, Italy
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Background and Study Aims: For several years now there has been an increasingly widespread use of a tissue adhesive in the treatment of bleeding gastric varices to achieve rapid, safe control of hemostasis and prevent rebleeding. In this study we report on our experience with the use of Bucrylate (Hystoacryl) for the treatment of gastric varices over a period of more than a decade.

Patients and Methods: Since 1988, 174 cirrhotic patients with actively bleeding gastric varices have been admitted to our department, where they received emergency treatment with injections of Bucrylate. Any associated nonbleeding esophageal varices were subjected to traditional sclerotherapy in combination with the Bucrylate treatment. The gastric varices were subdivided into four distinct groups according to the method advocated by Sarin in 1989. The patients underwent weekly sclerotherapy sessions until their varices were eradicated, and the follow-up with a mean of 36 months (range 9 - 90 months) consisted of endoscopy at 3, 6, and 12 months during the first year and then yearly checks to confirm obliteration of the varices.

Results: The hemostasis (97.1 %), early rebleeding (15.5 %), and hospital mortality (19.5 %) rates of the patients with bleeding gastric varices, treated with the tissue adhesive, were very similar to those of patients treated for esophageal varices over the same period (98.1 %, 13.0 %, and 16.4 %, respectively). The most frequent cause of death at 30 days was liver failure (76 % of cases), followed by hemorrhagic shock (8.8 %), and other less frequent causes. Sclerotherapy achieved obliteration rate for gastric varices (70 - 75 %) similar to that for esophageal varices in those patients with portal hypertension due to intrahepatic block (alcoholic and posthepatitis cirrhosis), but a rate of only 32 % in the group of patients with prehepatic block (splenoportomesenteric thrombosis), where surgery proved more effective (69 %). The medium- and long-term survival rates depended on the stability of the patients' liver conditions, on rapid, effective control of variceal hemostasis, and on complete, lasting obliteration of the gastric varices.

Conclusions: The use of Bucrylate in emergency sclerotherapy achieved results in bleeding gastric varices on a par with those obtained in esophageal varices in cases of alcoholic and posthepatitis cirrhosis. The group of patients with portal hypertension due to prehepatic block (splenoportal thrombosis) showed no benefit from sclerotherapy in terms of obliteration of gastric varices, but benefited from elective surgery. The choice of the obliterating treatment indicated may be facilitated by classifying gastric varices into distinct groups on the basis of anatomicotopographic criteria.


  • 1 Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices.  Gastrointest Endosc. 1986;  32 264-268
  • 2 Bretagne J F, Duducourt J C, Morisot D, et al. Is endoscopic variceal sclerotherapy effective for the treatment of gastric varices? (Abstract).  Dig Dis Sci. 1986;  31 5055
  • 3 Paquet K J, Mercado M A, Gad H A. Surgical procedures for bleeding esophago-gastric varices when sclerotherapy fails: a prospective study.  Am J Surg. 1990;  160 43-47
  • 4 Soehendra N, Nam Y C, Grimm H, et al. Endoscopic obliteration of large esophagogastric varices with Bucrylate.  Endoscopy. 1986;  18 25-26
  • 5 Ramond M J, Valla D, Gotlib J P, et al. Obturation endoscopique des varices oeso-gastriques par le Bucrylate. I Etude clinique de 49 malades.  Gastroenterol Clin Biol. 1986;  25 56-60
  • 6 Sarin S K, Kumar A. Gastric varices: profile, classification, and management.  Am J Gastroenterol. 1989;  84 1244-1249
  • 7 Sarin S K, Lahoti D, Saxena S, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.  Hepatology. 1992;  16 1343-1349
  • 8 Japanese Research Society for Portal Hypertension. The general rules for recording endoscopic findings of esophageal varices.  Jpn J Surg. 1980;  10 84-87
  • 9 Hashizume M, Ohta M, Veno K, et al. Endoscopic ligation of oesophageal varices compared with injection sclerotherapy: a prospective randomized trial.  Gastrointest Endosc. 1993;  39 (Suppl 2) 123-160
  • 10 Inaspettato G, Rodella L, Pratticò F, et al. La scleroterapia delle varici esofago-gastriche sanguinanti.  Acta Chir Ital. 1991;  47 988-990
  • 11 Inaspettato G, Kind R, Rodella L, et al. Immediate endoscopic sclerotherapy (I.E.S.) in the treatment of esophago-gastric bleeding varices; technique, complications and results of 312 patients in the 1988 - 1993's years (abstract).  Madrid; IGSC Congress 25 - 29 October 1993
  • 12 Feldman M, Feldman M, Jr. Gastric varices.  Gastroenterology. 1956;  30 318-321
  • 13 Hosking S W, Johnson A G. Gastric varices: a proposed classification leading to management.  Br J Surg. 1988;  75 195-196
  • 14 Hashizume M, Kitano S, Tamega H, et al. Endoscopic classification of gastric varices.  Gastrointest Endosc. 1990;  36 276-280
  • 15 Paquet K-J, Oberhammer E. Sclerotherapy of bleeding oesophageal varices by means of endoscopy.  Endoscopy. 1978;  10 7
  • 16 Watanabe K, Kimma K, Matsutani S, et al. Portal hemodynamics in patients with gastric varices.  Gastroenterology. 1988;  95 434-440
  • 17 Sarin S K. Long term follow-up of gastric variceal sclerotherapy: an eleven-year experience.  Gastrointest Endosc. 1997;  46 8-13
  • 18 Binmoeller K F, Soehendra N. “Superglue”: the answer to variceal bleeding and fundal varices.  Endoscopy. 1995;  27 392-396
  • 19 Gimson A ES, Westaby D, Williams R. Endoscopic sclerotherapy in the management of gastric variceal haemorrhage.  J Hepatol. 1991;  13 274-278
  • 20 Merican I, Burroughs A K. Gastric varices.  Eur J Gastroenterol Hepatol. 1992;  4 511-520
  • 21 Conn H O. Transjugular intrahepatic portal-systemic shunts: the status of the art.  Hepatology. 1993;  17 148-158
  • 22 Williams S G, Peters R A, Westaby D. Thrombin - an effective treatment for gastric variceal haemorrhage.  Gut. 1994;  35 (Suppl 9) 1287-1289
  • 23 Fujii Y, Sugawa C, Ozawa T, et al. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.  Am Surg. 1991;  57 (4) 222-225
  • 24 Snobl J, Van Buuren H R, Van Blankenstein M. Endoscopic injection therapy using thrombin: an effective and safe method for controlling oesophagogastric variceal bleeding.  Gastroenterology. 1992;  102 A891
  • 25 Feretis C, Dimopoulos C, Benakis P, et al. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices; a randomized prospective study.  Endoscopy. 1995;  27 355-357
  • 26 Oho K, Iwao T, Sumiao M, et al. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a non randomized study.  Endoscopy. 1995;  27 349-354
  • 27 Lehman R A, Hayes G J. The toxicity of 2-cyanoacrylate tissue adhesives: brain and blood vessels.  Surgery. 1967;  61 915-922
  • 28 See A, Florent C, Lamy P, et al. Cerebrovascular accidents after endoscopic obliteration of esophageal varices with bucrylate in two patients.  Gastroenterol Clin Biol. 1986;  10 (Suppl 8 - 9) 604-607
  • 29 Zambelli A. The New Italian Endoscopic Club: Complications of endoscopic sclerotherapy of esophageal varices.  G Ital Endosc Dig. 1991;  14 103-119
  • 30 Thakeb F, Salama Z, Salama H, et al. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding oesophagogastric varices.  Endoscopy. 1995;  27 358-364
  • 31 Prindiville T, Miller M, Trudeau W. Prognostic indicators in acute variceal hemorrhage after treatment by sclerotherapy.  Am J Surg. 1987;  72 655-659
  • 32 Infante-Rivard C, Esnaola S, Villenueve J P. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics.  Hepatology. 1987;  7 (Suppl 4) 660-664
  • 33 Heresbach D, Bretagne J F, Raoul J L, et al. Pronostic et facteurs pronostiques de l'hemorragie par rupture de varice chez le cirrhotique à l'ère de la sclérose endoscopique.  Gastroenterol Clin Biol. 1991;  15 838-844
  • 34 Sumino M, Toyonaga A, Tanikawa K. Evaluation of patient outcome following sclerotherapy for esophageal varices.  Gastroenterology. 1996;  31 387-393
  • 35 Inaspettato G, Kind R, Rodella L, et al. Immediate endoscopical sclerotherapy of acutely bleeding esophageal and gastric varices. A seven-yrs' (1988 - 1995) experience on 498 treated patients.  Ital J Dig Endosc. 1997;  20 21-28
  • 36 Westaby S GJ, Westaby D. Management of variceal haemorrhage.  Br Med J. 1994;  308 1213-1217
  • 37 Tran K M, Halter F. Endoscopic management of gastroesophageal varices.  Problems in General Surgery. Philadelphia: Lippincott Williams & Wilkins,. 1998;  15 (Suppl 4) 63-76

R. Kind, M.D.

I Divisione Clinicizzata di Chirurgia Generale Ospedale Civile Maggiore

Piazzale Stefani I 37126 Verona, Italy

Fax: Fax:+ 39-045-8345355

Email: E-mail:chirurgica.endoscopia@mail.azosp.vr.it